{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihulr4ah4ph3nenweqzhxyjtjwcizgp6kzilwzqecwzyiwysagxom",
    "uri": "at://did:plc:qx6osz4eyjjlnxy54n65xgxk/app.bsky.feed.post/3mnsahw63xmg2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicjyxalt77vd45eezlsixj67fd62jsdtsnjvyqufvjtuecsnuplai"
    },
    "mimeType": "image/jpeg",
    "size": 353668
  },
  "path": "/news/beauty/novo-nordisk-longevity-aesthetics-weight-loss/",
  "publishedAt": "2026-06-08T09:10:06.000Z",
  "site": "https://www.businessoffashion.com",
  "textContent": "Novo's blockbuster drugs could pull it into buzzier areas of healthcare, chief executive Mike Doustdar said, as the Ozempic maker seeks to lessen its reliance on obesity and diabetes.",
  "title": "Novo Nordisk Looks Beyond Weight Loss to Longevity and Aesthetics"
}